Author(s):
Prajakta A. Kakade, Shivkumar M. Sontakke, Avinash H. Hosmani, Indrajeet D. Gonjari
Email(s):
prajaktakakade4319@gmail.com
DOI:
10.52711/2231-5691.2025.00051
Address:
Prajakta A. Kakade1, Shivkumar M. Sontakke2, Avinash H. Hosmani3, Indrajeet D. Gonjari4
1Research Scholar, Department of Pharmaceutics, Government College of Pharmacy, Karad.
2Research Scholar, Department of Pharmaceutics, Government College of Pharmacy, Karad.
3Associate Professor, Department of Pharmaceutics, Government College of Pharmacy, Karad.
4Associate Professor, Department of Pharmaceutics, Government College of Pharmacy, Karad.
*Corresponding Author
Published In:
Volume - 15,
Issue - 3,
Year - 2025
ABSTRACT:
Artificial intelligence (AI) is transforming the present drug development and design method by tackling the obstacles addressed at each stage. AI improves the effectiveness of processes greatly by improving accuracy, reducing time and cost, using high-performance algorithms, and enabling computer-aided drug design (CADD). Efficient drug screening strategies are critical for discovering possible hit compounds among enormous amounts of data in compound repositories. The use of AI in drug development, comprising the screening of hit compounds as well as lead molecules, has shown to be more successful than traditional in vitro screening methods. This article examines advances in drug screening approaches made by AI-enhanced usage, machine learning (ML), along deep learning (DL) algorithms. It concentrates on AI applications for drug development, including screening methodologies and lead optimization approaches including quantitative structure-activity relationship (QSAR) modeling, pharmacophore modeling, de novo drug development, along high-throughput virtual screening. The discussion includes valuable insights into several parts of the drug screening process, focusing on the role of AI-based tools, pipelines, and case studies in reducing the intricacies of drug development.
Cite this article:
Prajakta A. Kakade, Shivkumar M. Sontakke, Avinash H. Hosmani, Indrajeet D. Gonjari. The Impact of Artificial Intelligence on Pharmacy Education, Research and Practice. Asian Journal of Pharmaceutical Research. 2025; 15(3):327-2. doi: 10.52711/2231-5691.2025.00051
Cite(Electronic):
Prajakta A. Kakade, Shivkumar M. Sontakke, Avinash H. Hosmani, Indrajeet D. Gonjari. The Impact of Artificial Intelligence on Pharmacy Education, Research and Practice. Asian Journal of Pharmaceutical Research. 2025; 15(3):327-2. doi: 10.52711/2231-5691.2025.00051 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2025-15-3-15
9. REFERENCES:
1. Dastha JF. Application of artificial intelligence to pharmacy and medicine Hospital. 1992; 27:312-322.
2. Sunarti S, Rahman F.F, Naufal M, Risky M, Febriyanto K, Masnina R. Artificial intelligence in healthcare Opportunities and Risk for future. 2021; 35: S67–S70.
3. Toepper M. Dissociating Normal Aging from Alzheimer’s Disease. 2017; 57: 331–352.
4. Honavar, V., Artificial intelligence: An overview. Artificial Intelligence Research Laboratory, 2006: p. 1-14.
5. Lopes, V. and L.A. Alexandre. An overview of blockchain integration with robotics and artificial intelligence. arXiv preprint arXiv.1810.00329, 2018.
6. Kawal, F. A Tour to the World of Artificial Intelligence. Cybernomics. 2020; 2(5): 33-35.
7. SIRI. [cited202220May]; Availablefrom: https://www.techtarget.com/searchm obilecomputing/definition/Siri.
8. What Is Alexa? [cited 2022 20 May]; Available from: https://itchronicles.com/artificial-intelligence/is-alexa-an-ai/#:~:text=What%20Is%20Alexa%3F,Echo%20and%20Dot% 20smart%20speakers.
9. How Google's Self-Driving Car Will Change Everything. [cited 2022 20 May]; Available from: https://www.eescorporation.com/do-self-driving-cars-use-ai/.
10. Das, S., et al., Applications of artificial intelligence in machine learning: review and prospect. International Journal of Computer Applications. 2015; 115(9).
11. https://www.scholarsresearchlibrary.com/articles/artificial- intelligence-in-pharmacy. pdf.
12. Vyas M, Thakur S and Riyaz B. Asian J Pharmaceutics, The Birth of AI. 2018; 12(2): 72-76.
13. Hargrove MB, Nelson DL and Cooper CL. Generating eustress by challenging employees: Helping people savor their work. Organizational Dynamics. 2013; 42: 61-69.
14. Mak KK and Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today. 2019; 24(3): 773-780.
15. Kawal F. A Tour to the World of Artificial Intelligence. Cybernomics. 2020; 2(5): 33-35
16. Okafo G. Adapting drug discovery to artificial intelligence. Drug Target Rev. 2018; 50-52
17. Lopes V and Alexandre LA. An overview of blockchain integration with robotics and artificial intelligence. arXiv preprint arXiv.1810.00329, 2018.
18. Sanjay S. Patel, Sparsh A. Shah. Artificial Intelligence: Comprehensive Overview and its Pharma Application. Asian Journal of Pharmacy and Technology. 12(4):337-8.
19. Tilva TM, Sorthiya AR, Vaghasiya MA, Khanpara PA and Faldu SD. A review on scope of artificial intelligence in pharma. Int J Pharm Sci and Res. 2024; 15(9): 2635-46. doi: 10.13040/IJPSR.0975-8232.15(9).2635-46.
20. Mulholland M. A comparison of classification in Artificial intelligence, induction versus a self-organising Neural networks Chemometrics and Intelligent Laboratory Systems. 1995; 30(1): 117-128.
21. Shakya, S. Analysis of artificial intelligence- b a s e d image Classification technique. Journal of Innovative Image Processing (JIIP). 2020; 2(01): 44-54.
22. Vaidehi Sunil Holey, Ajay W. Baitule. A Wide Application of Artificial Intelligence in Pharma Field. Asian Journal of Pharmaceutical Research. 2024; 14(4): 403-0.
23. Cherkasov A, Hilpert K, Jenssen H, Fjell CD, Waldbrook M and Mullaly SC. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol. 2009; 4(1): 65-74.
24. Agatonovic-Kustrin S, Beresford R. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed Anal. 2000; 22(5): 717-27.
25. Ajay I. Patel, Pooja K. Khunti, Amit J. Vyas, Ashok B. Patel. Explicating Artificial Intelligence: Applications in Medicine and Pharmacy. Asian Journal of Pharmacy and Technology. 12(4): 401-6.
26. Prasad Patil, Nripesh Kumar Nrip, Ashok Hajare, Digvijay Hajare, Mahadev K. Patil, Rajesh Kanthe, Anil T. Gaikwad. Artificial Intelligence and Tools in Pharmaceuticals: An Overview. Research Journal of Pharmacy and Technology. 2023; 16(4):2075-2.
27. USandsource=sh%2Fx%2FimApplication of AI.
28. Fazal MI, Patel ME and Tye J: Eur J Radiol. Research and Development of AI. 2018; 105: 246-250.
29. Li S, Yu L, Liu B, Lin Q and Huang J. Application analysis of ai technology combined with spiral CT scanning in early lung cancer screening. arXiv preprint arXiv. 2402; 04267. 2024 Jan 26.
30. Elsen R and Nayak S. Artificial Intelligence-Based 3D Printing Strategies for Bone Scaffold Fabrication and Its Application in Preclinical and Clinical Investigations. ACS Biomaterials Science and Engineering. 2024; 22.
31. Kamal H, Lopez V and Sheth SA. Front Neurol, Drug Develpoment of AI. 2018.
32. Sharma A. Revolutionizing Patient Care. Artificial Intelligence Applications in Nursing. Asian Journal of Nursing Education and Research. 2024; Apr; 14(2): 110-2.
33. Londhe VP, Chanshetti R, Dhole SN. Past, Present and Future. Asian Journal of Pharmaceutical Research. 2024; Jun 1; 14(2).
34. Sarfaraz Ahmad, Ambreen Shoaib, Sajid Ali, Sarfaraz Alam, Nawazish Alam, Maksood Ali, Ali Mujtaba, Ayaz Ahmad, Salahuddin Ansari, Mohammad Daud Ali. Epidemiology, risk, myths, pharmacotherapeutic management and socio-economic burden due to novel COVID-19: A recent update. Research J. Pharm. and Tech. 2020; 13(9):4435-4442.
35. Egemen D, Perkins RB, Cheung LC, Befano B, Rodriguez AC, Desai K, Lemay A, Ahmed SR, Antani S, Jeronimo J and Wentzensen N. Artificial intelligence–based image analysis in clinical testing: lessons from cervical cancer screening. JNCI. 2024; 116(1): 26-33.
36. Melanie M. An introduction to genetic algorithms. A Bradford book the MIT press Cambridge, Massachusetts. London, England.
37. Das S, Dey R and Nayak A. Artificial intelligence in pharmacy. Indian Journal of Pharmaceutical Education and Research. 2021; 55(2): 304-318. doi:10.5530/ijper.55.2.68.
38. Hasselgren C and Oprea TI. Artificial intelligence for drug discovery: Are we there yet? Annual Review of Pharmacology and Toxicology. 2024; 64: 527-50.
39. Mohamad Saleem Anis, Mohamed Azmi Hassali. Pharmaceutical Digital Marketing of Non-prescription Drugs: A Systematic Scoping Review. Research J. Pharmacy and Tech. 2022; 15(2):941-946.
40. Fogel, DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review. Contemporary Clinical Trials Communications. 2018;11:156–164.
41. Milgrom PR, Tadelis S. How Artificial Intelligence and Machine Learning Can Impact Market Design. National Bureau of Economic Research. 2006; 26:567-585.
42. Prescott JH, Lipka S, Baldwin S, Jr Sheppard NF, Maloney JM, Coppeta J, et al. Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nature Biotechnol. 2006; 24(4): 437-8.
43. Partiot E, Gorda B, Lutz W, Lebrun S, Khalfi P, Mora S, Charlot B, Majzoub K, Desagher S, Ganesh G and Colomb S. Organotypic culture of human brain explants as a preclinical model for AI- driven antiviral studies. EMBO Molecular Medicine. 2024;1-23.
44. Prachnakorn N, Preecha K, Sri-U-Thai T, Jaroenyod T, Sawang K, Patwong N and Wattanapisit A. Incorporating artificial intelligence into a workshop on scientific and scholarly report writing for preclinical medical students. Medical Teacher. 2024; 1-3.
45. Available from https://images.app.goo.gl/4WYrZwGP2fc5fmkUABenefit of AI for Healthcare.
46. Nichols JA, Herbert CHW, Baker MAB. Biophys Rev Machine learning Application of AI. 2018; 11: 111–118.
47. Podlogar F, Šibanc R, Gašperlin M. Evolutionary artifcial neural networks as tools for predicting the internal structure of microemulsions. J Pharm Pharmaceut Sci. 2008; 11(1): 67-76.